Mass. biopharma industry loses jobs, but investment rebounds
Massachusetts is witnessing a strange paradox in its powerhouse biopharma sector, where a sudden dip in employment is being countered by a surge of fresh capital. A new report from MassBio reveals that the industry shrank for the first time in over twenty years, losing roughly 3,600 positions last year. These cuts hit hardest in
